LT - TARGETED DELIVERY OF BOTULINUM TOXIN FOR THE TREATMENT AND PREVENTION OF TRIGEMINAL AUTONOMIC CEPHALGIAS, MIGRAINE AND VASCULAR CONDITIONS
EN - TARGETED DELIVERY OF BOTULINUM TOXIN FOR THE TREATMENT AND PREVENTION OF TRIGEMINAL AUTONOMIC CEPHALGIAS, MIGRAINE AND VASCULAR CONDITIONS
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 38/48 |
|
European patent
| (11) |
Number of the document |
1846018 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
05855968.3 |
|
Date of filing the European patent application |
2005-12-29 |
| (97) |
Date of publication of the European application |
2007-10-24 |
| (45) |
Date of publication and mention of the grant of the patent |
2014-07-09
|
| (46) |
Date of publication of the claims translation |
|
PCT application
| (86) |
Number |
PCT/US2005/047483 |
|
Date |
2005-12-29 |
PCT application publication
| (87) |
Number |
WO 2006/083455 |
|
Date |
2006-08-10 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
593641 P |
2005-02-01
|
US |
Inventors
| (72) |
Blumenfeld, Andrew M., US
|
Grantee
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
Title
| (54) |
TARGETED DELIVERY OF BOTULINUM TOXIN FOR THE TREATMENT AND PREVENTION OF TRIGEMINAL AUTONOMIC CEPHALGIAS, MIGRAINE AND VASCULAR CONDITIONS |
| |
TARGETED DELIVERY OF BOTULINUM TOXIN FOR THE TREATMENT AND PREVENTION OF TRIGEMINAL AUTONOMIC CEPHALGIAS, MIGRAINE AND VASCULAR CONDITIONS |
